TENAX THERAPEUTICS INC (TENX)
US88032L6056 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.79M | 2.12M | 5.58M | 6.25M | 4.91M | |||
| Marketable Securities | N/A | N/A | 0.00 | 460.00K | 490.00K | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.89M | 1.09M | 110.00K | 80.00K | 780.00K | |||
| Total Current Assets | 11.68M | 3.21M | 5.69M | 6.80M | 6.18M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 190.00K | 290.00K | 60.00K | 180.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.12K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Total Non-Current Assets | 1.12K | 190.00K | 300.00K | 70.00K | 190.00K | |||
| TOTAL ASSETS | 11.68M | 3.40M | 5.99M | 6.87M | 6.37M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 500.90K | 620.00K | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 120.00K | N/A | |||
| Accrued Expenses | 1.01M | 780.00K | 700.00K | 1.24M | 870.00K | |||
| Accounts Payable | 2.07M | 450.00K | 860.00K | 760.00K | 1.66M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 3.59M | 1.85M | 1.56M | 2.12M | 2.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 120.00K | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 0.00 | 60.00K | 180.00K | 0.00 | 60.00K | |||
| Total Non-Current Liabilities | 0.00 | 60.00K | 190.00K | 120.00K | 60.00K | |||
| TOTAL LIABILITIES | 3.59M | 1.91M | 1.75M | 2.24M | 2.59M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -297.25M | -289.54M | -278.49M | -246.02M | -236.17M | |||
| Additional Paid In Capital | 305.35M | 291.03M | 282.74M | 250.64M | 239.94M | |||
| Common Shares | 30.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 298.28K | 2.29M | 1.26M | 630.00K | 340.00K | |||
| Tangible Book Value per Share | 27.15 | 0.65 | 3.37 | 7.35 | 11.09 | |||
| Total Shareholders' Equity | 8.10M | 1.49M | 4.24M | 4.63M | 3.77M | |||
| TOTAL LIABILITIES AND EQUITY | 11.68M | 3.40M | 5.99M | 6.87M | 6.37M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.03 | N/A | |||
| Current Ratio | 3.26 | 1.74 | 3.65 | 3.21 | 2.44 | |||
| Return On Assets (ROA) | -65.99% | -325.00% | -550.58% | -143.38% | -131.71% | |||
| Return On Equity (ROE) | -95.22% | -741.61% | -777.83% | -212.74% | -222.55% | |||
All data in USD